State of Wisconsin Investment Board’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,173
Closed -$84.1K 2405
2025
Q2
$84.1K Buy
+11,173
New +$89.8K ﹤0.01% 2282
2025
Q1
Sell
-18,657
Closed -$227K 2259
2024
Q4
$227K Sell
18,657
-7,727
-29% -$111K ﹤0.01% 2110
2024
Q3
$442K Buy
26,384
+10,137
+62% +$180K ﹤0.01% 1923
2024
Q2
$283K Sell
16,247
-3,848
-19% -$81.9K ﹤0.01% 2042
2024
Q1
$342K Buy
+20,095
New +$310K ﹤0.01% 1916
2023
Q4
Sell
-15,258
Closed -$138K 2407
2023
Q3
$138K Buy
+15,258
New +$159K ﹤0.01% 2320
2023
Q2
Sell
-12,945
Closed -$132K 2377
2023
Q1
$132K Sell
12,945
-1,465
-10% -$16.1K ﹤0.01% 2348
2022
Q4
$152K Sell
14,410
-797
-5% -$9.68K ﹤0.01% 2289
2022
Q3
$195K Sell
15,207
-654
-4% -$8.81K ﹤0.01% 2412
2022
Q2
$203K Sell
15,861
-18,839
-54% -$214K ﹤0.01% 2483
2022
Q1
$363K Buy
34,700
+17,600
+103% +$238K ﹤0.01% 2045
2021
Q4
$264K Hold
17,100
﹤0.01% 2038
2021
Q3
$386K Buy
17,100
+2,028
+13% +$54.2K ﹤0.01% 1756
2021
Q2
$388K Buy
+15,072
New +$464K ﹤0.01% 1754

Other funds holding CGEM

State of Wisconsin Investment Board's CGEM Position: Q3 2025 in Review

State of Wisconsin Investment Board sold out of Cullinan Oncology (CGEM) in Q3 2025, closing a stake of 11,173 shares — an estimated $84.1K sold.

State of Wisconsin Investment Board first reported a position in CGEM in Q2 2021 and held it in 14 quarters. The position peaked at $442K in Q3 2024. 145 funds tracked by Wall St. Rank hold CGEM as of Q3 2025.

  • State of Wisconsin Investment Board reported no remaining Cullinan Oncology position as of Q3 2025 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 11,173 Cullinan Oncology shares in Q3 2025, an estimated $84.1K.
  • State of Wisconsin Investment Board first reported a position in Cullinan Oncology in Q2 2021 and held it in 14 quarters.
  • State of Wisconsin Investment Board's Cullinan Oncology position peaked at $442K in Q3 2024.
  • 145 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2025.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2025, filed 14 Nov 2025.